FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to applying a quinazolinone compound of formula: wherein R3 has the values presented in the description and the patent claim, in the free form or in the form of salt. Also, the invention refers to a pharmaceutical composition exhibiting vanilloid receptor antagonist activity on the basis of said compounds.
EFFECT: there are produced new compounds and pharmaceutical composition on their basis which can find application in medicine for treating and preventing pain, gastrointestinal disorder.
12 cl, 30 ex
Authors
Dates
2012-05-10—Published
2005-06-08—Filed